OR
OR Royalties Inc. NYSE$36.09
Mkt Cap $6.8B
52w Low $22.40
53.4% of range
52w High $48.06
50d MA $40.23
200d MA $36.62
P/E (TTM)
32.8x
EV/EBITDA
26.8x
P/B
4.8x
Debt/Equity
0.0x
ROE
—
P/FCF
31.3x
RSI (14)
—
ATR (14)
—
Beta
1.37
50d MA
$40.23
200d MA
$36.62
Avg Volume
1.3M
About
OR Royalties, Inc. engages in the acquisition, mining, and exploration of precious metals, streams, and other royalties. It holds interests in the Canadian Malartic mine. The company was founded on April 29, 2014 and is headquartered in Montreal, Canada.
Recent Earnings
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | 1M% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 18, 2026 | AMC | 0.31 | 0.32 | +3.2% | 43.53 | -1.9% | -3.7% | +0.3% | +2.8% | +4.4% | +5.3% | -24.5% | — |
| Nov 5, 2025 | AMC | 0.19 | 0.22 | +15.8% | 31.29 | +1.1% | -0.7% | +2.1% | +3.4% | +3.6% | +6.6% | +8.5% | — |
| Aug 5, 2025 | AMC | 0.17 | 0.13 | -23.5% | 29.49 | +0.2% | +0.6% | +3.0% | +3.1% | +3.9% | +4.2% | +13.7% | — |
| May 7, 2025 | AMC | 0.13 | 0.16 | +23.1% | 23.98 | -0.2% | -1.1% | +1.6% | -6.3% | -3.1% | -5.6% | +8.1% | — |
| Feb 19, 2025 | AMC | 0.14 | 0.16 | +14.3% | 19.51 | -1.0% | -2.4% | -4.6% | -4.8% | -6.0% | -4.5% | +4.2% | — |
| Nov 6, 2024 | AMC | 0.11 | 0.11 | +0.0% | 20.32 | -0.5% | +1.1% | -0.4% | -5.8% | -8.6% | -9.4% | -5.7% | — |
| Aug 6, 2024 | AMC | 0.12 | 0.13 | +8.3% | 16.53 | +0.9% | -3.4% | -2.4% | -1.4% | +2.4% | +3.4% | +1.8% | — |
| May 8, 2024 | AMC | 0.11 | 0.12 | +9.1% | 15.87 | +0.7% | +1.6% | +3.0% | +1.5% | +3.0% | +3.6% | +5.2% | — |
| Feb 20, 2024 | AMC | 0.11 | 0.12 | +9.1% | 14.09 | -2.4% | -1.7% | -2.4% | +0.8% | -0.3% | -1.3% | +11.9% | — |
| Nov 8, 2023 | AMC | 0.10 | 0.09 | -10.0% | 12.53 | -2.4% | +4.9% | +1.4% | -3.9% | -2.6% | -2.8% | +9.3% | — |
Recent Analyst Ratings
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 10 | RBC Capital | Maintains | Outperform → Outperform | — | $39.65 | $40.09 | +1.1% | -0.5% | -0.5% | +1.2% | +1.2% | +3.1% |
| Jan 26 | Scotiabank | Maintains | Sector Perform → Sector Perform | — | $45.20 | $46.11 | +2.0% | +0.8% | +1.8% | +3.6% | +1.1% | -12.7% |
| Oct 23 | Scotiabank | Downgrade | Sector Outperform → Sector Perform | — | $34.67 | $35.18 | +1.5% | -2.8% | -3.8% | -8.6% | -8.2% | -8.0% |
| Oct 10 | Raymond James | Downgrade | Outperform → Market Perform | — | $37.59 | $37.56 | -0.1% | +0.2% | +3.1% | +1.9% | +2.8% | +6.5% |
| Oct 6 | Jefferies | Downgrade | Buy → Hold | — | $39.42 | $39.58 | +0.4% | +2.5% | +3.6% | +3.3% | -4.6% | -4.4% |
| Sep 12 | Raymond James | Maintains | Outperform → Outperform | — | $35.89 | $36.11 | +0.6% | +0.2% | +2.8% | -2.0% | -1.2% | -0.4% |
| Jul 7 | Scotiabank | Maintains | Sector Outperform → Sector Outperform | — | $26.03 | $25.89 | -0.5% | +4.7% | -0.8% | +2.3% | +3.0% | +7.1% |
| Apr 14 | Scotiabank | Upgrade | Sector Perform → Sector Outperform | — | $22.40 | $22.20 | -0.9% | +1.6% | +3.8% | +5.9% | +4.2% | +5.0% |
| Apr 4 | RBC Capital | Maintains | Outperform → Outperform | — | $20.98 | $20.51 | -2.2% | -5.6% | -7.1% | -8.3% | -2.7% | +4.0% |
| Feb 27 | Scotiabank | Maintains | Sector Perform → Sector Perform | — | $18.64 | $18.36 | -1.5% | -3.9% | -1.7% | -3.4% | -1.1% | +1.3% |
Recent Filings
8-K · 1.02
!! High
Rigel Pharmaceuticals Inc. (New) -- 8-K 1.02: Material Agreement Terminated
Rigel Pharmaceuticals terminated its CNS disease program effective June 15, 2026, eliminating a potential revenue stream and narrowing its pipeline focus to other therapeutic areas.
Apr 21
8-K · 1.01
!! High
Unknown — 8-K 1.01: Material Agreement
Healthcare Technologies Innovations' partnership with SecureKloud Technologies could expand cybersecurity and data protection capabilities, potentially opening new revenue streams and improving operational resilience for investors seeking growth.
Apr 10
8-K · 1.02
!! High
Unknown — 8-K 1.02: Material Agreement Terminated
Kaken's termination of this supply and royalty agreement eliminates a revenue stream for the company, likely pressuring earnings and cash flow, which investors should monitor for potential stock weakness.
Mar 20
Data updated apr 26, 2026 5:46pm
· Source: massive.com